Clinical Trial Update: Using Tumour DNA and Proteins to Better Understand How Pancreatic Cancer Responds to Treatment [NA]

View source ↗

Summary

This clinical trial update describes a biomarker-focused study using tumor DNA and protein profiling to understand how pancreatic ductal adenocarcinoma responds…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Borderline Resectable Pancreatic Ductal Adenocarcinoma
• Pancreatic Ductal Adenocarcinoma
• Resectable Pancreatic Ductal Adenocarcinoma

Snippet

Sponsor: British Columbia Cancer Agency | Conditions: Pancreatic Ductal Adenocarcinoma, Resectable Pancreatic Ductal Adenocarcinoma | NA | Status: RECRUITING